![Warfarin Sodium, amorphous - Warfarin Sodium, amorphous; API; EP, USP, JP, ANVISA; [129-06-6]](https://www.europages.com/filestore/opt/product/7e/fa/product_57914449.jpg)
![Warfarin Sodium, amorphous - Warfarin Sodium, amorphous; API; EP, USP, JP, ANVISA; [129-06-6]](https://www.europages.com/filestore/opt/product/a2/7a/product_7ff316e4.jpg)
![Warfarin Sodium, amorphous - Warfarin Sodium, amorphous; API; EP, USP, JP, ANVISA; [129-06-6]](https://www.europages.com/filestore/opt/product/5c/3b/product_2f416f11.jpg)
Description
Warfarin Sodium, amorphous is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph. Its CAS-N° reads [129-06-6]. It is used to treat or prevent blood clots in veins or arteries, which can reduce the risk of stroke, heart attack, or other serious conditions. Detailed specification, Certificate of Analysis and samples are available on request.
Chemistry, organic - raw materials and derivatives
Product features
| CAS | 129-06-6 |
| Product Information | API |
| Route of Synthesis | Synthetic |
| Patent Expiry | EU, US - expired |
| Indication | Anticoagulant, Tromboembosism |
| Dosage | Oral and iv formulation |
OTHER PRODUCTS FROM THIS COMPANY
-
Doxapram HydrochlorideDoxapram Hydrochloride; Active Pharmaceutical Ingredient; EP, USP, JP, 7081-53-0
VIEW THE PRODUCT PAGE
-
Doxazosin MesylateDoxazosin Mesylate; Active Pharmaceutical Ingredient; EP; CAS 77883-43-3
VIEW THE PRODUCT PAGE
-
(R)-3-Quinuclidinol(R)-3-Quinuclidinol for chemical synthesis
VIEW THE PRODUCT PAGE
-
KetoprofenKetoprofen; Active Pharmaceutical Ingredient; EP, JP;CAS 22071-15-4
VIEW THE PRODUCT PAGE
Need more information from the seller?
More information on the company's website
http://ky.to/www.midas-pharma....
A similar page for your product?
Sign up your company and create your own online product pages on EUROPAGES
Sign up
Already registered? Publish your products